Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2023-02-23 | 2023-05-06 | 185468 |
| APO-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-07-12 | 2024-07-26 | 232829 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-08-14 | 2025-11-07 | 265284 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-19 | 2025-08-22 | 260690 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-07-03 | 2025-10-24 | 261641 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260156 |
| APO-LEVOTHYROXINE | 175MCG | TABLET | Resolved | 2025-06-12 | 2025-08-22 | 260159 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-12 | 2025-10-10 | 260162 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Actual shortage | 2025-05-15 | 2026-01-15 | 257519 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260669 |
| APO-LEVOTHYROXINE | 125MCG | TABLET | Resolved | 2025-06-19 | 2025-10-31 | 260678 |
| APO-LEVOTHYROXINE | 137MCG | TABLET | Resolved | 2025-06-19 | 2025-10-10 | 260687 |
| APO-LEVOTHYROXINE | 200MCG | TABLET | Resolved | 2025-05-15 | 2025-07-18 | 257525 |
| APO-LEVOTHYROXINE | 112MCG | TABLET | Resolved | 2025-06-19 | 2025-11-07 | 260693 |
| APO-LEVOTHYROXINE | 100MCG | TABLET | Resolved | 2025-06-20 | 2025-10-16 | 260817 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-31 | 260820 |
| APO-LEVOTHYROXINE | 88MCG | TABLET | Resolved | 2025-06-20 | 2025-10-10 | 260823 |
| APO-LEVOTHYROXINE | 50MCG | TABLET | Resolved | 2025-07-10 | 2025-11-14 | 262425 |
| APO-LEVOTHYROXINE | 75MCG | TABLET | Resolved | 2025-07-10 | 2025-10-10 | 262429 |
| APO-LEVOTHYROXINE | 150MCG | TABLET | Resolved | 2025-07-03 | 2025-10-10 | 261632 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |